Clinical practice and metabolic consequences of olanzapine use in schizophrenia: results from a national survey in Spain L.I. Muñoz-Manchado; M. Bernardo; J.M. Villagrán-Moreno; E. Fernández-Egea;

Antipsychotic drug prescription sequence analysis in relation to death occurrence and cardiometabolic drug usage: A retrospective longitudinal study Pawe¿ Zagozdzon; Piotr Dorozynski; Przemys¿aw Waszak; Adam Harasimowicz; Tomasz Dziubich;